<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00990951</url>
  </required_header>
  <id_info>
    <org_study_id>MJ 3001-09</org_study_id>
    <nct_id>NCT00990951</nct_id>
  </id_info>
  <brief_title>Study of Efficacy of Association of Senna Alexandrina Mill and Associations on Functional Intestinal Constipation</brief_title>
  <official_title>Double-blind, Randomized, Placebo-controlled Study of Efficacy of Association of Senna Alexandrina, Cassia Fistula, Tamarindus Indica, Coriandrum Sativum, Periandra Mediterranea in Patients With Functional Intestinal Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marjan Industria e Comercio ltda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marjan Industria e Comercio ltda</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of association of Senna alexandrina
      Mill (sena), Cassia fistula L., Tamarindus indica L., Coriandrum sativum L., Periandra
      mediterranea Taub. in patients with functional constipation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase III trial, placebo-controlled with a parallel-group design.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    The study was interrupted by recruitment failure.
  </why_stopped>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>average frequency of bowel movements measured at baseline and at 2 weeks of treatment</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of consecutive days that patients do not evacuate</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of stools with pain and difficulty</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>degree of improvement of constipation according to the subjective evaluation of the volunteer, measured by the scores of the Global Assessment of the patient</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Senna alexandrina and associations</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Association of Senna alexandrina Mill (sena), Cassia fistula L., Tamarindus indica L., Coriandrum sativum L., Periandra mediterranea Taub</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Senna alexandrina and associations</intervention_name>
    <description>Drugs: Senna alexandrina Mill (sena), Cassia fistula L., Tamarindus indica L., Coriandrum sativum L., Periandra mediterranea Taub
1 tablet PO twice a day</description>
    <arm_group_label>Senna alexandrina and associations</arm_group_label>
    <other_name>Brand name: Tamaril</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 18-65 years with functional constipation by ROME IIII criteria

          -  In the opinion of the investigator the patient will adhere to the protocol

          -  Voluntary able to understand the nature and purpose of the study, including the risks
             and adverse effects and with intent to cooperate with the researcher and act in
             accordance with the requirements of the entire protocol, which was confirmed by
             signing the Consent Informed

        Exclusion Criteria:

          -  hypersensitivity to any component

          -  pregnant or lactating

          -  abdominal pain of unknown etiology

          -  suspected intestinal occlusion and sub-occlusion

          -  suspected abdominal inflammatory conditions (as appendicitis, peritonitis, cystitis,
             endometritis)

          -  Crohn disease and colitis

          -  Suspected intestinal constipation due abdominal surgery, neurological disorders (as
             aganglionoses, Parkinson disease, medullar tumor, stroke, multiple sclerosis),
             systemic sclerosis, multiple myeloma, scleroderma

          -  Subjects with congenital mega colon, anorectal congenital malformation, inflammatory
             bowel disease or intestinal carcinoma

          -  history of mal-absorption diseases

          -  history of anemia, weight loss or anal bleeding

          -  history of hypothyroidism, hyperthyroidism and insulin-dependent diabetes mellitus

          -  known of positive result for human immunodeficiency virus test

          -  heart, liver, lung or kidney important condition

          -  drug or alcohol dependence

          -  knowledge or suspicion of malignancy

          -  body mass index &lt; 18

          -  body mass index &gt; 30

          -  participation on any experimental study 12 months prior this study

          -  familiar history of colon carcinoma or inflammatory disease

          -  Lack of adherence to the procedures of the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria EA Moraes, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Ceara - UNIFAC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departamento de Fisiologia e Farmacologia</name>
      <address>
        <city>Cear√°</city>
        <state>Fortaleza</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2009</study_first_submitted>
  <study_first_submitted_qc>October 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2009</study_first_posted>
  <last_update_submitted>July 7, 2014</last_update_submitted>
  <last_update_submitted_qc>July 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sennoside A&amp;B</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

